Name: Prescribing Hemodialysis: A Guide to Urea Modeling (en Inglés)
SKU: 58124635
Price: 778331.00 COP
Availability: InStock
Author: Depner, T. a.
ISBN: 9781461288114

portada Prescribing Hemodialysis: A Guide to Urea Modeling (en Inglés)

Prescribing Hemodialysis: A Guide to Urea Modeling (en Inglés)

Formato

Libro Físico

Autor

T. a. Depner

Editorial

Springer

Idioma

Inglés

N° páginas

292

Encuadernación

Tapa Blanda

Dimensiones

23.4x15.6x1.7 cm

Peso

0.45 kg.

ISBN13

9781461288114

Categorías

Enfermedades y trastornos
Medicina renal y nefrología
Jardinería

Prescribing Hemodialysis: A Guide to Urea Modeling (en Inglés)

T. a. Depner (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 26 días háb.

$ 1.297.219$ 778.331

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 778.331

¡Envío Gratis! Llega entre el 13 Oct y el 20 Oct a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Prescribing Hemodialysis: A Guide to Urea Modeling (en Inglés)"

What regulation shall we have for the operation? Shall a man transfuse he knows not what. to correct he knows not what. God knows how (l)? Dr. Henry Stubbs Royal College of Physicians circa 1670 If dialysis therapy were a new phannaceutical product being evaluated by the FDA now, it might not be approved for marketing. The recommended dose, its potential toxicity, the side effects of under-or over-dialysis as well as its efficacy have been the subject of very few studies. The high mortality rate associated with the treatment may raise a few eyebrows. That it is a life-saving modality of treatment is undoubtedly true for more than 100,000 patients in the United States and for more than a million patients world- wide. Because dialysis has extended the lives of many people by a variable period of time, most nephrologists have "rested on their laurels" and did not vigorously pursue studies to optimize these treatments. But facts have a way of intruding in all our lives and the facts are that the overall mortality rate of dialysis patients in the United States is rising and stands close to 25% per year and is closer to 33% per year for patients between the ages of 65 and 74 (2). These mortality figures are considerably higher for age-adjusted dialysis populations in Europe and particu- larly in Japan, and certainly for the age-adjusted nonnal population.